The First Take – Pharma's pandemic takes a new twist
FirstTake on Pharma - Pharma News and Analysis Podcast
English - December 03, 2021 15:00 - 10 minutes - 7.54 MB - ★★★★★ - 2 ratingsScience pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The First Take – Pfizer’s antiviral haul, BMS lays out a growth strategy and Biogen’s week to forget
Next Episode: The FirstTake Podcast – Three doses are better than two
FirstWord Pharma PLUS editors Matthew Dennis and Simon King discuss the potential impact of the Omicron variant on the efficacy of COVID-19 vaccines, how GlaxoSmithKline and Sanofi are making moves to keep their vaccines portfolios at the cutting edge of R&D and whether there is a meaningful future for Merck & Co.’s COVID-19 antiviral molnupiravir after this week’s close-run AdCom vote.